Join Podium on Sept. 5 at 1 p.m. (EST) for a free webinar that discusses the benefits of an omni-channel communication strategy.
Description: While a vast majority of the customer's research is happening online, there comes a time when your customers will eventually need to take that process offline. Businesses that are winning are providing consumers with a number of different options to connect and drive them to the physical location, including text, web chat, email, phone, and others.
Over the course of this webinar, we will discuss the typical customer journey and show you how an omni-channel strategy can improve the experience and drive more business. Key takeaways include:
- What it means to have an omni-channel strategy
- How today’s consumer finds and connects with a pest control service
- Why connecting your business to Google Click-to-Message and Facebook Messenger will drive more leads
- The benefits of having a unified inbox for all of your customer interactions
CLICK HERE to register.
Our current question asks: Do your company's service professionals use handheld computers?
Click here to participate.
The move aligns two of Public Health’s most respected companies in an effort to better serve vector management programs across the US and Caribbean.
“This partnership creates an exciting future for VBC’s Public Health business, its customers, and the people we protect,” said Steve Krause, Global Business Director for VBC’s Public Health and Forestry businesses. “We operate in a highly technical industry, and ADAPCO’s proven history of excellence in the design and operation of equipment, field support, customer service, and the handling of our solutions made it a clear choice going forward.”
Krause indicates the partnership blossomed through ADAPCO’s work with VBC’s award winning technology across five Western states. VBC won a 2017 Chicago Innovation Award for its Wide Area Larvicide Spray (WALS™) application technology. Developed through more than 20 years of global research, WALS leverages VectoBac®, VBC’s advanced Bacillus thuringiensis spp. israelensis Strain AM65-52 (Bti) technology using a breakthrough method for delivering biorational larvicides into the hard-to-reach areas where Dengue- and Zika-transmitting mosquitoes breed.
“We are excited to foster a new era of vector control and mosquito suppression,” said Steve Burt, Managing Director, Specialty Ag/Hort, Azelis Americas. “This alignment of industry-leading teams – Valent Biosciences’ leadership in the space of biorational larvicides, together with ADAPCO’s field and application expertise – will usher in a transformational future for vector control in these regions.”
The effective date for the distribution agreement is October 1, 2018.